undamentalytics Newsletter
Sign in

Funds (13F)

Glenview Capital Management, LLC

Backtest from 16 Aug 2013 to 2 Nov 2026 · weekly · hypothetical

Watch this strategy
Return a year
+14.8%
S&P 500 +14.1%
Last 12 months
+25.0%
S&P 500 +12.1%
Sharpe ratio
0.65
S&P 500 0.78
Biggest drop
−42.8%
S&P 500 −31.8%
$10.0k$20.0k$40.0k 2013201520172019202120232025 $62.3k$57.0k
StrategyS&P 500 $10,000 in Glenview Capital Management, LLC from 16 Aug 2013 against the S&P 500 (total return) over the same dates, marked weekly, log scale. Hypothetical: before taxes and trading costs.

About

Copies Glenview Capital Management, LLC's quarterly 13F holdings in the companies we cover, weighted by reported value: it buys on the first trading day after each 13F is filed (up to 45 days after the quarter) and holds until the next filing. A 13F shows long US-listed positions only, at the quarter's end, so this misses shorts, cash, bonds, non-US holdings and trading within the quarter.

Glenview Capital Management, LLC's 13F holdings →

Key statistics

MeasureStrategyS&P 500
Return a year (compound)+14.8%+14.1%
Total return+523%+470%
Last 12 months+25.0%+12.1%
Last 3 months+1.5%—
Last month+1.0%—
This year so far+17.5%—
Volatility a year22.0%16.0%
Sharpe ratio0.650.78
Biggest drop−42.8%−31.8%
Beta to the S&P 5001.161.00
Alpha a year (t-statistic)−0.2% (−0.05)—
Share of weeks up58%—

Sharpe ratio uses returns above the 3-month Treasury bill rate. Alpha is the yearly return left after allowing for the strategy's exposure to the S&P 500 (CAPM); a t-statistic below about 2 means it cannot be told apart from luck.

Insights

CompanyWeightHeld sinceReturn since
GPN12.9%——
CVS10.0%——
THC8.4%——
TMO6.3%——
AMZN6.1%——
A5.2%——
DHR4.4%——
META4.0%——
AMD3.5%——
TEVA3.5%——
VTRS3.1%——
UBER2.6%——
CNC2.4%——
BFLY2.4%——
CI2.3%——
HUM2.0%——
XYZ1.8%——
DKS1.8%——
GENI1.6%——
ONTO1.6%——
LLY1.4%——
UAL1.4%——
EYE1.2%——
CSCO1.0%——
ESI0.9%——
AMAT0.9%——
MKSI0.9%——
FUN0.9%——
STM0.8%——
ABBV0.8%——
AZN0.7%——
BLCO0.6%——
BKR0.6%——
ELV0.5%——
MCHP0.5%——
BRKR0.3%——
DOCN0.3%——
PRMB0.2%——
BSX0.1%——
CAH0.1%——
TECH0.1%——

Weighted by reported value in the latest 13F, held until the next filing.

PeriodReturn a yearS&P 500SharpeS&P 500Biggest dropBetaAlpha (t)
Whole backtest16 Aug 2013 to 2 Nov 2026+14.8%+14.1%0.650.78−42.8%1.16−0.2% (−0.05)
2018 onwards5 Jan 2018 to 2 Nov 2026+15.0%+13.9%0.570.66−42.8%1.19+0.3% (0.07)
Last three years3 Nov 2023 to 2 Nov 2026+24.6%+21.8%1.031.16−17.1%0.94+4.0% (0.52)
Last year7 Nov 2025 to 2 Nov 2026+23.5%+14.2%1.030.84−13.2%1.01+8.6% (0.62)
DateCompanyAction
21 Aug 2026STMBought
21 Aug 2026MKSIBought
21 Aug 2026MCHPBought
21 Aug 2026LLYBought
21 Aug 2026ELVBought
21 Aug 2026CAHBought
21 Aug 2026BSXBought
21 Aug 2026BRKRBought
21 Aug 2026AZNBought
21 Aug 2026ABBVBought
21 Aug 2026ABought
22 May 2026PRMBBought
22 May 2026INTCBought
22 May 2026HUMBought
22 May 2026CSCOBought
22 May 2026BKRBought
22 May 2026AKAMBought
20 Feb 2026VSTBought
20 Feb 2026TLNBought
20 Feb 2026SXTBought
20 Feb 2026SOLSBought
20 Feb 2026QBought
20 Feb 2026METCBought
20 Feb 2026GENIBought
20 Feb 2026FUNBought

Dated at the rebalance that made the change.

DateCompanyAction
21 Aug 2026ZSold
21 Aug 2026USFDSold
21 Aug 2026SGRYSold
21 Aug 2026MYGNSold
21 Aug 2026LIONSold
21 Aug 2026LADSold
21 Aug 2026INTCSold
21 Aug 2026GTMSold
21 Aug 2026DXCSold
21 Aug 2026BIIBSold
21 Aug 2026AKAMSold
22 May 2026VSTSold
22 May 2026TLNSold
22 May 2026SXTSold
22 May 2026SOLSSold
22 May 2026SNPSSold
22 May 2026RTOSold
22 May 2026RHSold
22 May 2026QSold
22 May 2026MKSISold
22 May 2026METCSold
22 May 2026MCKSold
22 May 2026KNXSold
22 May 2026IQVSold
22 May 2026EXPESold

Dated at the rebalance that made the change.

Backtests are hypothetical and use today's listed companies only, which flatters results. Past performance does not predict future returns. This is research, not investment advice. How we backtest